Regarding the processing of pathological specimens, the importance of sustainable quality control is emphasized in the recommendations for HER2 testing in BC by the American Society of Clinical Oncology/College of American Pathologists guidelines [49]. The gene discussed is ERBB2; the disease is breast cancer.